COMMUNITY-BASED PHARMACEUTICAL CARE: A CONTROLLED TRIAL

基于社区的药物治疗：对照试验

• 批准号: 2430868
• 负责人: Morris Weinberger
• 金额: $ 53.17万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-06-01 至 2000-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2430868
• 关键词: automated medical record system; clinical research; community health services; computer assisted patient care; computer network; health care model; health care personnel education; health care service evaluation; health education; human subject; interview; job satisfaction; pharmacists; pharmacy; quality of life; respiratory airflow disorder; respiratory disorder chemotherapy; therapy compliance

DESCRIPTION: (taken from abstract). Using reactive airways disease (RAD) as a model, the applicants propose to develop algorithms, materials, and an educational program to facilitate pharmaceutical care. They propose to conduct a randomized, controlled trial. They will provide developed materials and patient-specific clinical information, displayed on their computer workstations, when filling prescriptions. The patient educational materials will be printed and videotaped. Clinical information will come from the patients' electronic medical records stored in a network linking six hospitals, 24 free-standing clinics and neighborhood health centers, and a pharmacy chain filling half the prescriptions in Central Indiana. The clinical information displayed will include peak expiratory flow rates (PEFRs), evidence of recent hospitalizations or emergency room visits for respiratory disease, and an indicator of medication compliance calculated from the timing of refills. The sites for this trial will be 20 drugstores in central Indianapolis (10 randomized to intervention status, 10 to control status) located near the six computer-linked hospitals. Adult patients with RAD who fill most of their drugs at one of the study drugstores and use one of the six hospitals for acute care will be recruited by a letter from the drugstore chain. There will be one intervention group of 460 patients (who will also be given peak flow meters) and two control groups: 460 patients also given a peak flow meter and 460 patients without meters to control for a possible effect of the peak flow meters themselves. Those patients who agree to participate will be interviewed in their homes at baseline, 6, and 12 months. The following clinical information will be obtained during the in-home interviews and from monthly telephone calls to supplement data in their computer records: recent exacerbations of respiratory disease, medication compliance, and PEFR. Comorbidity information and the following outcome data will also be obtained during the in-home interviews: health-related quality of life (HRQOL), satisfaction with their health care, and satisfaction with their pharmacists and pharmacy. Pharmacists' job satisfaction and attitudes toward pharmaceutical care will also be assessed. Each patient will be followed for 1 year during which the effectiveness and cost-effectiveness of the intervention will be measured on patient outcomes that include PEFR, acute exacerbations of respiratory disease, medication compliance, and HRQOL.

描述：（取摘要）。 使用反应性气道疾病（RAD） 作为模型，申请人建议开发算法，材料和 促进药物护理的教育计划。 他们建议 进行随机，对照试验。 他们将提供发达的 材料和特定于患者的临床信息，显示在其上 计算机工作站，填写处方时。 患者的教育 材料将被打印和录像。 临床信息将到来 从患者的电子病历中存储在网络链接中 六家医院，24个独立诊所和邻里健康中心，以及 一家药房连锁店填充了印第安纳州中部处方的一半。 这 显示的临床信息将包括峰值呼气流量 （PEFR），最近住院或急诊室就诊的证据 呼吸道疾病和计算药物合规指标 从补充时间。 该试验的站点将是20家药店 在印第安纳波利斯中部（10个随机到干预状态，10 状态）位于六家电脑连接医院附近。 成年患者 RAD在其中一家研究药店中填充大多数药物，然后使用一个 在六家急诊医院中，将由该书招募 药房链。 将有一个由460名患者组成的干预组（也将给予他们 峰值流量计）和两个对照组：460名患者也给出了峰值 流量计和460名没有米的患者可以控制效果 峰流量计。 那些同意参加的患者 将在基线，6和12个月的家中接受采访。 这 在家中将获得以下临床信息 访谈和每月电话，以补充数据中的数据 计算机记录：呼吸道疾病，药物的最新恶化 合规性和PEFR。 合并症信息和以下结果 还将在家庭访谈中获得数据：与健康有关 生活质量（HRQOL），对医疗保健的满意度以及 对他们的药剂师和药房满意。 药剂师的工作 还将评估对药物护理的满意度和态度。 每个患者将被遵循1年，在此期间 干预措施的成本效益将根据患者预后进行衡量 包括PEFR，急性加重呼吸道疾病，药物 合规性和HRQOL。